Option Care Health Debt to Equity Ratio 2012-2025 | OPCH
Current and historical debt to equity ratio values for Option Care Health (OPCH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Option Care Health debt/equity for the three months ending December 31, 2025 was 0.87.
| Option Care Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $2.13B | $1.33B | 1.61 |
| 2025-09-30 | $2.12B | $1.36B | 1.56 |
| 2025-06-30 | $2.02B | $1.36B | 1.49 |
| 2025-03-31 | $1.96B | $1.35B | 1.45 |
| 2024-12-31 | $2.02B | $1.40B | 1.44 |
| 2024-09-30 | $2.00B | $1.43B | 1.40 |
| 2024-06-30 | $1.94B | $1.41B | 1.37 |
| 2024-03-31 | $1.82B | $1.43B | 1.27 |
| 2023-12-31 | $1.80B | $1.42B | 1.26 |
| 2023-09-30 | $1.80B | $1.44B | 1.25 |
| 2023-06-30 | $1.85B | $1.48B | 1.25 |
| 2023-03-31 | $1.78B | $1.35B | 1.32 |
| 2022-12-31 | $1.73B | $1.39B | 1.25 |
| 2022-09-30 | $1.74B | $1.34B | 1.30 |
| 2022-06-30 | $1.70B | $1.29B | 1.32 |
| 2022-03-31 | $1.66B | $1.22B | 1.36 |
| 2021-12-31 | $1.62B | $1.18B | 1.37 |
| 2021-09-30 | $1.69B | $1.10B | 1.54 |
| 2021-06-30 | $1.66B | $1.06B | 1.57 |
| 2021-03-31 | $1.62B | $1.02B | 1.59 |
| 2020-12-31 | $1.63B | $1.02B | 1.61 |
| 2020-09-30 | $1.68B | $0.99B | 1.69 |
| 2020-06-30 | $1.76B | $0.87B | 2.03 |
| 2020-03-31 | $1.74B | $0.87B | 2.00 |
| 2019-12-31 | $1.68B | $0.91B | 1.86 |
| 2019-09-30 | $1.66B | $0.92B | 1.80 |
| 2019-06-30 | $0.68B | $-0.08B | -8.99 |
| 2019-03-31 | $0.66B | $-0.06B | -10.94 |
| 2018-12-31 | $0.83B | $0.60B | 1.37 |
| 2018-09-30 | $0.62B | $-0.04B | -16.94 |
| 2018-06-30 | $0.60B | $-0.03B | -20.21 |
| 2018-03-31 | $0.60B | $-0.02B | -38.92 |
| 2017-12-31 | $0.69B | $-0.09B | -8.12 |
| 2017-09-30 | $0.59B | $0.00B | 408.89 |
| 2017-06-30 | $0.60B | $0.01B | 44.84 |
| 2017-03-31 | $0.58B | $0.03B | 21.70 |
| 2016-12-31 | $0.57B | $0.04B | 14.76 |
| 2016-09-30 | $0.55B | $0.05B | 12.13 |
| 2016-06-30 | $0.49B | $0.05B | 10.03 |
| 2016-03-31 | $0.53B | $-0.03B | -20.05 |
| 2015-12-31 | $0.55B | $-0.02B | -30.55 |
| 2015-09-30 | $0.56B | $0.00B | -1577.07 |
| 2015-06-30 | $0.56B | $0.02B | 38.28 |
| 2015-03-31 | $0.59B | $0.26B | 2.27 |
| 2014-12-31 | $0.61B | $0.22B | 2.80 |
| 2014-09-30 | $0.58B | $0.28B | 2.08 |
| 2014-06-30 | $0.57B | $0.32B | 1.81 |
| 2014-03-31 | $0.57B | $0.33B | 1.71 |
| 2013-12-31 | $0.58B | $0.36B | 1.64 |
| 2013-09-30 | $0.56B | $0.37B | 1.50 |
| 2013-06-30 | $0.35B | $0.40B | 0.86 |
| 2013-03-31 | $0.38B | $0.29B | 1.32 |
| 2012-12-31 | $0.35B | $0.29B | 1.19 |
| 2012-09-30 | $0.37B | $0.28B | 1.32 |
| 2012-06-30 | $0.38B | $0.30B | 1.29 |
| 2012-03-31 | $0.46B | $0.22B | 2.14 |
| 2011-12-31 | $0.46B | $0.22B | 2.15 |
| 2011-09-30 | $0.44B | $0.21B | 2.15 |
| 2011-06-30 | $0.44B | $0.20B | 2.17 |
| 2011-03-31 | $0.45B | $0.20B | 2.19 |
| 2010-12-31 | $0.46B | $0.20B | 2.32 |
| 2010-09-30 | $0.48B | $0.27B | 1.80 |
| 2010-06-30 | $0.46B | $0.26B | 1.75 |
| 2010-03-31 | $0.46B | $0.26B | 1.79 |
| 2009-12-31 | $0.13B | $0.16B | 0.84 |
| 2009-09-30 | $0.13B | $0.11B | 1.13 |
| 2009-06-30 | $0.13B | $0.11B | 1.22 |
| 2009-03-31 | $0.13B | $0.10B | 1.28 |
| 2008-12-31 | $0.15B | $0.10B | 1.59 |
| 2008-09-30 | $0.17B | $0.17B | 0.96 |
| 2008-06-30 | $0.15B | $0.17B | 0.88 |
| 2008-03-31 | $0.15B | $0.17B | 0.89 |
| 2007-12-31 | $0.13B | $0.17B | 0.79 |
| 2007-09-30 | $0.13B | $0.16B | 0.80 |
| 2007-06-30 | $0.14B | $0.16B | 0.87 |
| 2007-03-31 | $0.15B | $0.16B | 0.96 |
| 2006-12-31 | $0.14B | $0.16B | 0.89 |
| 2006-09-30 | $0.12B | $0.19B | 0.61 |
| 2006-06-30 | $0.12B | $0.19B | 0.63 |
| 2006-03-31 | $0.12B | $0.20B | 0.59 |
| 2005-12-31 | $0.10B | $0.20B | 0.53 |
| 2005-09-30 | $0.07B | $0.22B | 0.34 |
| 2005-06-30 | $0.07B | $0.22B | 0.34 |
| 2005-03-31 | $0.08B | $0.22B | 0.38 |
| 2004-12-31 | $0.07B | $0.12B | 0.61 |
| 2004-09-30 | $0.07B | $0.11B | 0.57 |
| 2004-06-30 | $0.07B | $0.11B | 0.60 |
| 2004-03-31 | $0.07B | $0.11B | 0.68 |
| 2003-12-31 | $0.06B | $0.11B | 0.60 |
| 2003-09-30 | $0.07B | $0.10B | 0.66 |
| 2003-06-30 | $0.08B | $0.10B | 0.83 |
| 2003-03-31 | $0.09B | $0.09B | 0.93 |
| 2002-12-31 | $0.09B | $0.09B | 0.93 |
| 2002-09-30 | $0.09B | $0.09B | 1.02 |
| 2002-06-30 | $0.10B | $0.08B | 1.27 |
| 2002-03-31 | $0.11B | $0.08B | 1.41 |
| 2001-12-31 | $0.08B | $0.06B | 1.32 |
| 2001-09-30 | $0.08B | $0.06B | 1.40 |
| 2001-06-30 | $0.08B | $0.05B | 1.64 |
| 2001-03-31 | $0.08B | $0.04B | 2.01 |
| 2000-12-31 | $0.08B | $0.04B | 2.05 |
| 2000-09-30 | $0.07B | $0.04B | 1.69 |
| 2000-06-30 | $0.08B | $0.04B | 2.08 |
| 2000-03-31 | $0.08B | $0.04B | 2.25 |
| 1999-12-31 | $0.08B | $0.04B | 2.29 |
| 1999-09-30 | $0.09B | $0.04B | 2.07 |
| 1999-06-30 | $0.06B | $0.04B | 1.59 |
| 1999-03-31 | $0.06B | $0.04B | 1.52 |
| 1998-12-31 | $0.07B | $0.04B | 1.82 |
| 1998-09-30 | $0.07B | $0.04B | 1.62 |
| 1998-06-30 | $0.05B | $0.02B | 2.56 |
| 1998-03-31 | $0.05B | $0.02B | 2.46 |
| 1997-12-31 | $0.05B | $0.02B | 2.73 |
| 1997-09-30 | $0.03B | $0.03B | 1.06 |
| 1997-06-30 | $0.03B | $0.03B | 0.82 |
| 1997-03-31 | $0.00B | $0.00B | 1.84 |
| 1996-12-31 | $0.00B | $0.00B | 1.53 |
| 1996-09-30 | $0.00B | 0.00 | |
| 1996-06-30 | $0.00B | $0.00B | 0.08 |
| 1996-03-31 | $0.00B | $0.00B | 0.05 |
| 1995-12-31 | $0.00B | $0.00B | 0.08 |
| 1995-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.553B | $5.650B |
| Option Care Health Inc provides infusion and home care management solutions. The Company offers products, services and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders and heart failures. Option Care Health Inc., formerly known as BioScrip Inc., is based in Denver, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |